ニコチン経口溶解性薄膜市場調査レポート

Nicotine Oral Dissolvable Thin Films Market Research Report

ニコチン経口溶解性薄膜市場調査レポート : 製品 (プレス式定量吸入器、呼吸作動式定量吸入器)、噴射剤タイプ (HFA 134A、HFA 227EA、HFA 152A)、テクノロジー (肺プラットフォーム技術、鼻プラットフォーム技術)、適応症 (喘息、COPD、その他)、流通チャネル (病院薬局、小売薬局、オンライン)薬局) および地域 (北米、ヨーロッパ、アジア太平洋、およびRoW) - 2032年までの市場予測
Nicotine Oral Dissolvable Thin Films Market Research Report Information by Strength (1mg, 2mg, and Others), by Route of Administration (Tongue and Buccal), and by Age Group (Adults and Adolescents), by Sales Channel (Online and Offline), and by Region (North America, Europe, Asia-Pacific, and Rest of the World) - Forecast till 2032

商品番号 : SMB-69935

出版社Market Research Future
出版年月2024年11月
ページ数146
価格タイプシングルユーザライセンス
価格USD 4,950
種別英文調査報告書

Overview of the Market

In 2023, the market for nicotine oral dissolvable thin films was estimated to be worth USD 0.10 billion. With a compound annual growth rate (CAGR) of 3.86% from 2024 to 2032, the market for nicotine oral dissolveable thin films is expected to increase from USD 0.11 billion in 2024 to USD 0.15 billion by 2032.

2023 年のニコチン経口溶解性薄膜市場は 1 億米ドルの価値があると推定されています。 2024年から2032年までの年平均成長率(CAGR)は3.86%で、ニコチン経口溶解性薄膜市場は2024年の1.1億米ドルから2032年までに1.5億米ドルに増加すると予想されています。

Increased efforts to stop smoking are driving a significant demand for nicotine oral dissolvable thin films, which is accelerating market expansion in a number of ways. Public health campaigns and government initiatives, such those run by the Office on Smoking and Health (OSH), are actively urging people to quit smoking or reduce their nicotine intake. Programs designed to reduce tobacco use support these efforts by providing resources and skills for implementing effective quitting techniques.

Moreover, the worldwide market for nicotine oral dissolvable thin films is mostly driven by the advantages of oral thin film (OTF) technology. A few of the main advantages that support market expansion are listed below. OTFs are a handy and portable way to give nicotine because they dissolve quickly in the mouth and don’t require water. They are available for users to use quietly from anywhere at any time.

Perspectives on Market Segments

The market for nicotine oral dissolvable thin films has been divided into segments based on strength, including 1 mg and 2 mg.

The market has been divided into tongue and buccal segments based on the administration route.

The market for nicotine oral dissolvable thin films has been divided into two segments based on age: adults and adolescents.

The market has been divided into online and offline segments based on the sales channel.

Geographic Perspectives

The market for nicotine oral dissolvable thin films in North America was valued at USD 31.20 million in 2023 and is anticipated to expand at a compound annual growth rate (CAGR) of 3.86% over the course of the forecast period. The United States and Canada are two more divisions of North America. The growing frequency of smoking-related health problems and growing awareness of smoking cessation aids are driving the market for nicotine oral dissolvable thin films in North America.

The market for nicotine oral dissolvable films in Europe was valued at USD 44.48 million in 2023 and is anticipated to expand at a compound annual growth rate (CAGR) of 3.46% over the course of the forecast period. The market for nicotine oral dissolvable thin films in Europe is expected to increase significantly over the next several years because to the growing demand for these products and the presence of competitors.

The market for nicotine oral dissolvable films in the Asia-Pacific region was valued at USD 20.74 million in 2023 and is anticipated to expand at a compound annual growth rate (CAGR) of 4.77% over the course of the forecast period. Because of rising health consciousness, urbanization, and the high prevalence of smoking in nations like China, South Korea, India, and Japan, the market for nicotine oral dissolvable thin films in the Asia-Pacific region is expanding significantly.

Key Players

Nicoccino Holding AB (Japan), AdhexPharma (France), ARx, LLC (US), ZIM Laboratories Limited (India), LTS Lohmann Therapie-Systeme AG (Germany), NAL Pharma (China), INVENTZ Lifesciences (India), Renejix Pharma Solutions (US), and DK Livkon Healthcare Pvt. Ltd. (India) are important players in the nicotine oral dissolvable thin film market.

TABLE OF CONTENTS

1 EXECUTIVE SUMMARY

2 MARKET INTRODUCTION

2.1 DEFINITION

2.2 SCOPE OF THE STUDY

2.3 RESEARCH OBJECTIVE

2.4 MARKET STRUCTURE

3 RESEARCH METHODOLOGY

3.1 OVERVIEW

3.2 DATA FLOW

3.2.1 DATA MINING PROCESS

3.3 PURCHASED DATABASE:

3.4 SECONDARY SOURCES:

3.4.1 SECONDARY RESEARCH DATA FLOW:

3.5 PRIMARY RESEARCH:

3.5.1 PRIMARY RESEARCH DATA FLOW:

3.5.2 PRIMARY RESEARCH: NUMBER OF INTERVIEWS CONDUCTED

3.5.3 PRIMARY RESEARCH: REGIONAL COVERAGE

3.6 APPROACHES FOR MARKET SIZE ESTIMATION:

3.6.1 REVENUE ANALYSIS APPROACH

3.7 DATA FORECASTING

3.7.1 DATA FORECASTING TYPE

3.8 DATA MODELING

3.8.1 MICROECONOMIC FACTOR ANALYSIS:

3.8.2 DATA MODELING:

3.9 TEAMS AND ANALYST CONTRIBUTION

4 MARKET DYNAMICS

4.1 INTRODUCTION

4.2 DRIVERS

4.2.1 INCREASING SMOKING AND TOBACCO CESSATION EFFORTS

4.2.2 ADVANTAGE OF ORAL THIN FILM DRIVES THE MARKET GROWTH

4.3 RESTRAINTS

4.3.1 STRINGENT REGULATORY POLICIES

4.3.2 PRESENCE OF NICOTINE REPLACEMENT THERAPIES

4.3.3 PATENT PROTECTION OF NICOTINE ORAL THIN FILM PRODUCTS

4.4 OPPORTUNITY

4.4.1 INITIATION TO BUILD AND LAUNCH ORAL THIN FILM MANUFACTURING

4.4.2 INNOVATION ASSOCIATED WITH NICOTINE ORAL THIN FILM

5 MARKET FACTOR ANALYSIS

5.1 VALUE CHAIN ANALYSIS

5.1.1 R&D

5.1.2 MANUFACTURING

5.1.3 DISTRIBUTION & SALES

5.2 PORTER’S FIVE FORCES MODEL

5.2.1 THREAT OF NEW ENTRANTS

5.2.2 BARGAINING POWER OF SUPPLIERS

5.2.3 THREAT OF SUBSTITUTES

5.2.4 BARGAINING POWER OF BUYERS

5.2.5 INTENSITY OF RIVALRY

5.3 IMPACT OF COVID-19 ON THE GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET

5.4 QUALITATIVE INFORMATION ON PACKAGING OF NICOTINE ORAL DISSOLVABLE THIN FILMS

5.4.1 PACKAGING MATERIALS

5.4.1.1 FOIL, PAPER, OR PLASTIC POUCHES

5.4.1.2 SINGLE POUCH AND ALUMINUM POUCH

5.4.1.3 BLISTER CARD WITH MULTIPLE UNITS

5.4.1.4 BARRIER FILMS

5.4.2 LABELING AND INFORMATION FOR NICOTINE ORAL DISSOLVABLE THIN FILMS

5.4.2.1 REGULATORY COMPLIANCE

5.4.2.2 NICOTINE DOSAGE

5.4.2.3 WARNINGS AND PRECAUTIONS

5.4.2.4 EXPIRATION DATES

5.5 QUALITATIVE INFORMATION ON END USE OF NICOTINE ORAL DISSOLVABLE THIN FILMS

5.5.1 CHALLENGES IN FORMULATION, STABILITY, AND MANUFACTURING OF ORAL THIN FILM (OTF)

5.5.2 STRINGENT REGULATORY POLICIES FOR THE GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILM MARKET

5.6 QUALITATIVE INFORMATION ON END USE OF NICOTINE ORAL DISSOLVABLE THIN FILMS

5.6.1 SMOKERS & EX-SMOKERS

5.6.2 CONVENIENCE AND DISCREET USE

5.7 PRICING ANALYSIS, BY REGION 2023 (USD)

6 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH

6.1 OVERVIEW

6.2 1MG

6.3 2MG

6.4 OTHERS

7 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION

7.1 OVERVIEW

7.2 TONGUE

7.3 BUCCAL

8 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP

8.1 OVERVIEW

8.2 ADULTS

8.3 ADOLESCENTS

9 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL

9.1 OVERVIEW

9.2 ONLINE

9.3 OFFLINE

10 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION

10.1 OVERVIEW

10.2 NORTH AMERICA

10.2.1 US

10.2.2 CANADA

10.3 EUROPE

10.3.1 GERMANY

10.3.2 FRANCE

10.3.3 UK

10.3.4 ITALY

10.3.5 SPAIN

10.3.6 REST OF EUROPE

10.4 ASIA-PACIFIC

10.4.1 CHINA

10.4.2 INDIA

10.4.3 JAPAN

10.4.4 SOUTH KOREA

10.4.5 AUSTRALIA

10.4.6 REST OF ASIA-PACIFIC

10.5 REST OF THE WORLD

10.5.1 LATIN AMERICA

10.5.2 MIDDLE EAST & AFRICA

11 COMPETITIVE LANDSCAPE

11.1 INTRODUCTION

11.2 MARKET SHARE ANALYSIS, 2023

11.3 COMPETITOR DASHBOARD

11.4 PUBLIC PLAYERS STOCK SUMMARY

11.5 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL

11.6 KEY DEVELOPMENTS & GROWTH STRATEGIES

11.6.1 AGREEMENT

11.6.2 EXPANSION

11.6.3 PRODUCT APPROVAL

11.6.4 PRODUCT RECOGNITION

12 COMPANY PROFILES

12.1 NICOCCINO HOLDING AB

12.1.1 COMPANY OVERVIEW

12.1.2 FINANCIAL OVERVIEW

12.1.3 PRODUCTS OFFERED

12.1.4 ADDITIONAL INFORMATION

12.1.5 KEY DEVELOPMENTS

12.1.6 SWOT ANALYSIS

12.1.7 KEY STRATEGIES

12.2 NISSHA CO., LTD.

12.2.1 COMPANY OVERVIEW

12.2.2 FINANCIAL OVERVIEW

12.2.3 PRODUCTS OFFERED

12.2.4 ADDITIONAL INFORMATION

12.2.5 KEY DEVELOPMENTS

12.2.6 SWOT ANALYSIS

12.2.7 KEY STRATEGIES

12.3 ADHEXPHARMA

12.3.1 COMPANY OVERVIEW

12.3.2 FINANCIAL OVERVIEW

12.3.3 PRODUCT OFFERED

12.3.4 ADDITIONAL INFORMATION

12.3.5 KEY DEVELOPMENTS

12.3.6 KEY STRATEGIES

12.4 ARX, LLC

12.4.1 COMPANY OVERVIEW

12.4.2 FINANCIAL OVERVIEW

12.4.3 PRODUCTS OFFERED

12.4.4 ADDITIONAL INFORMATION

12.4.5 KEY DEVELOPMENTS

12.4.6 KEY STRATEGIES

12.5 ZIM LABORATORIES LIMITED

12.5.1 COMPANY OVERVIEW

12.5.2 FINANCIAL OVERVIEW

12.5.3 PRODUCTS OFFERED

12.5.4 ADDITIONAL INFORMATION

12.5.5 KEY DEVELOPMENTS

12.5.6 SWOT ANALYSIS

12.5.7 KEY STRATEGIES

12.6 LTS LOHMANN THERAPIE-SYSTEME AG

12.6.1 COMPANY OVERVIEW

12.6.2 FINANCIAL OVERVIEW

12.6.3 PRODUCTS OFFERED

12.6.4 ADDITIONAL INFORMATION

12.6.5 KEY DEVELOPMENTS

12.6.6 SWOT ANALYSIS

12.6.7 KEY STRATEGIES

12.7 NAL PHARMA

12.7.1 COMPANY OVERVIEW

12.7.2 FINANCIAL OVERVIEW

12.7.3 PRODUCTS OFFERED

12.7.4 ADDITIONAL INFORMATION

12.7.5 KEY DEVELOPMENTS

12.7.6 KEY STRATEGIES

12.8 INVENTZ

12.8.1 COMPANY OVERVIEW

12.8.2 FINANCIAL OVERVIEW

12.8.3 PRODUCTS OFFERED

12.8.4 ADDITIONAL INFORMATION

12.8.5 KEY DEVELOPMENTS

12.8.6 SWOT ANALYSIS

12.8.7 KEY STRATEGIES

12.9 RENEJIX PHARMA SOLUTIONS

12.9.1 COMPANY OVERVIEW

12.9.2 FINANCIAL OVERVIEW

12.9.3 SERVICES OFFERED

12.9.4 ADDITIONAL INFORMATION

12.9.5 KEY DEVELOPMENTS

12.9.6 KEY STRATEGIES

12.10 DK LIVKON PVT. LTD

12.10.1 COMPANY OVERVIEW

12.10.2 FINANCIAL OVERVIEW

12.10.3 SERVICES OFFERED

12.10.4 ADDITIONAL INFORMATION

12.10.5 KEY DEVELOPMENTS

12.10.6 KEY STRATEGIES

13 DATA CITATIONS

LIST OF TABLES

TABLE 1 QFD MODELING FOR MARKET SHARE ASSESSMENT

TABLE 2 ADVANTAGE OF ORAL THIN FILM

TABLE 3 PATENT PROTECTION OF NICOTINE ORAL THIN FILM PRODUCTS

TABLE 4 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 5 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR 1MG, BY REGION, 2019–2032 (USD MILLION)

TABLE 6 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR 2MG, BY REGION, 2019–2032 (USD MILLION)

TABLE 7 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR OTHERS, BY REGION, 2019–2032 (USD MILLION)

TABLE 8 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 9 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR TONGUE, BY REGION, 2019–2032 (USD MILLION)

TABLE 10 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR BUCCAL, BY REGION, 2019–2032 (USD MILLION)

TABLE 11 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 12 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR ADULTS, BY REGION, 2019–2032 (USD MILLION)

TABLE 13 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR ADOLESCENTS, BY REGION, 2019–2032 (USD MILLION)

TABLE 14 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 15 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR ONLINE, BY REGION, 2019–2032 (USD MILLION)

TABLE 16 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, FOR OFFLINE, BY REGION, 2019–2032 (USD MILLION)

TABLE 17 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2019–2032 (USD MILLION)

TABLE 18 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 19 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 20 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 21 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 22 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 23 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 24 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 25 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 26 US: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 27 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 28 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 29 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 30 CANADA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 31 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 1 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 2 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 3 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 4 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 5 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 6 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 7 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 8 GERMANY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 9 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 10 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 11 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 12 FRANCE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 13 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 14 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 15 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 16 UK: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 17 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 18 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 19 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 20 ITALY: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 21 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 22 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 23 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 24 SPAIN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 25 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 26 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 27 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 28 REST OF EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 29 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2019–2032 (USD MILLION)

TABLE 1 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 2 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 3 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 4 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 5 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 6 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 7 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 8 CHINA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 9 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 10 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 11 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 12 INDIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 13 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 14 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 15 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 16 JAPAN: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 17 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 18 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 19 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 20 SOUTH KOREA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 21 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 22 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 23 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 24 AUSTRALIA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 1 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 2 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 3 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 4 REST OF ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 5 REST OT THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2019–2032 (USD MILLION)

TABLE 1 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 2 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 3 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 4 REST OF THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 5 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 6 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 7 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 8 LATIN AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 9 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2019–2032 (USD MILLION)

TABLE 10 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2019–2032 (USD MILLION)

TABLE 11 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2019–2032 (USD MILLION)

TABLE 12 MIDDLE EAST & AFRICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2019–2032 (USD MILLION)

TABLE 13 PUBLIC PLAYERS STOCK SUMMARY

TABLE 14 COMPARATIVE ANALYSIS: KEY PLAYERS FINANICAL

TABLE 15 AGREEMEENT

TABLE 16 EXPANSION

TABLE 17 PRODUCT APPROVAL

TABLE 18 PRODUCT RECOGNITION

TABLE 19 NICOCCINO HOLDING AB: PRODUCTS OFFERED

TABLE 20 NICOCCINO HOLDING AB: ADDITIONAL INFORMATION

TABLE 21 NISSHA CO., LTD.: PRODUCTS OFFERED

TABLE 22 NISSHA CO., LTD.: ADDITIONAL INFORMATION

TABLE 23 ADHEXPHARMA: PRODUCTS OFFERED

TABLE 24 ADHEXPHARMA: ADDITIONAL INFORMATION

TABLE 25 ARX, LLC: PRODUCTS OFFERED

TABLE 26 ARX, LLC: ADDITIONAL INFORMATION

TABLE 27 ZIM LABORATORIES LIMITED: PRODUCTS OFFERED

TABLE 28 ZIM LABORATORIES LIMITED: ADDITIONAL INFORMATION

TABLE 29 ZIM LABORATORIES LIMITED: KEY DEVELOPMENTS

TABLE 30 LTS LOHMANN THERAPIE-SYSTEME AG: PRODUCTS OFFERED

TABLE 31 LTS LOHMANN THERAPIE-SYSTEME AG: ADDITIONAL INFORMATION

TABLE 32 NAL PHARMA: PRODUCTS OFFERED

TABLE 33 ADDITIONAL INFORMATION

TABLE 34 INVENTZ: PRODUCTS OFFERED

TABLE 35 INVENTZ: ADDITIONAL INFORMATION

TABLE 36 RENEJIX PHARMA SOLUTIONS: SERVICES OFFERED

TABLE 37 RENEJIX PHARMA SOLUTIONS: ADDITIONAL INFORMATION

TABLE 38 DK LIVKON PVT. LTD: SERVICES OFFERED

TABLE 39 DK LIVKON PVT. LTD: ADDITIONAL INFORMATION

LIST OF FIGURES

FIGURE 1 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET: STRUCTURE

FIGURE 2 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET: MARKET GROWTH FACTOR ANALYSIS (2023-2032)

FIGURE 3 DRIVER IMPACT ANALYSIS (2023-2032)

FIGURE 4 RESTRAINT IMPACT ANALYSIS (2023-2032)

FIGURE 5 VALUE CHAIN ANALYSIS: GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILM MARKET

FIGURE 6 MANUFACTURING PROCESS FOR THE NICOTINE ORAL DISSOLVABLE THIN FILM

FIGURE 7 PORTER’S FIVE FORCES ANALYSIS: GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET

FIGURE 8 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, STRENGTH SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)

FIGURE 9 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY STRENGTH, 2023 & 2032 (USD MILLION)

FIGURE 10 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY STRENGTH, 2023

FIGURE 11 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, ROUTE OF ADMINISTRATION SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)

FIGURE 12 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY ROUTE OF ADMINISTRATION, 2023 & 2032 (USD MILLION)

FIGURE 13 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY ROUTE OF ADMINISTRATION, 2023

FIGURE 14 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, AGE GROUP SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)

FIGURE 15 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY AGE GROUP, 2023 & 2032 (USD MILLION)

FIGURE 16 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY AGE GROUP, 2023

FIGURE 17 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, SALES CHANNEL SEGMENT ATTRACTIVENESS, 2023-2032 (USD MILLION)

FIGURE 18 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY SALES CHANNEL, 2023 & 2032 (USD MILLION)

FIGURE 19 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY SALES CHANNEL, 2023

FIGURE 20 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)

FIGURE 21 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY REGION, 2023

FIGURE 22 NORTH AMERICA MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2032 (USD MILLION)

FIGURE 23 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)

FIGURE 24 NORTH AMERICA: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY COUNTRY, 2023

FIGURE 25 EUROPE MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2032 (USD MILLION)

FIGURE 26 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)

FIGURE 27 EUROPE: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY REGION, 2023

FIGURE 28 ASIA-PACIFIC MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2030 (USD MILLION)

FIGURE 29 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY COUNTRY, 2023 & 2032 (USD MILLION)

FIGURE 30 ASIA-PACIFIC: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY COUNTRY, 2023

FIGURE 31 REST OF THE WORLD MARKET ANALYSIS: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, 2019-2032 (USD MILLION)

FIGURE 32 REST OT THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET, BY REGION, 2023 & 2032 (USD MILLION)

FIGURE 33 REST OT THE WORLD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET SHARE (%), BY REGION, 2023

FIGURE 34 GLOBAL NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET PLAYERS: COMPETITIVE ANALYSIS, 2023

FIGURE 35 COMPETITOR DASHBOARD: NICOTINE ORAL DISSOLVABLE THIN FILMS MARKET

FIGURE 36 NICOCCINO HOLDING AB: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 37 NICOCCINO HOLDING AB: SWOT ANALYSIS

FIGURE 38 NISSHA CO., LTD.: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 39 NISSHA CO., LTD.: SWOT ANALYSIS

FIGURE 40 ZIM LABORATORIES LIMITED: FINANCIAL OVERVIEW SNAPSHOT

FIGURE 41 ZIM LABORATORIES LIMITED: SWOT ANALYSIS

FIGURE 42 LTS LOHMANN THERAPIE-SYSTEME AG: SWOT ANALYSIS

FIGURE 43 INVENTZ: SWOT ANALYSIS